• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.13% Nasdaq Up 0.14%

    Provectus Biopharmaceuticals, Inc. (PVCT)

    -NYSE MKT
    0.35 Down 0.03(8.50%) May 26, 4:00PM EDT
    Prev Close:0.38
    Open:0.39
    Bid:0.35 x 5000
    Ask:4.90 x 4000
    1y Target Est:3.50
    Beta:1.15647
    Earnings Date:Aug 4 - Aug 8 (Est.)
    Day's Range:0.35 - 0.40
    52wk Range:0.32 - 0.84
    Volume:602,567
    Avg Vol (3m):272,194
    Market Cap:74.49M
    P/E (ttm):N/A
    EPS (ttm):-0.14
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PVCT

    Comparison

    Symbol% ChgMkt Cap
    PVCTDown 8.50%74.49M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Provectus Biopharmaceuticals, Inc., a biopharmaceutical company, engages in developing ethical pharmaceuticals for oncology and dermatology indications. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback